Share ownership DiaSorin S.p.A.

DIA

IT0003492391

Medical Equipment, Supplies & Distribution

Market Closed - Borsa Italiana Other stock markets 16:45:00 08/05/2026 BST			5-day change	1st Jan Change
63.20 ^EUR	-1.62%		+8.93%	-7.90%

05-08	DiaSorin S.p.A., Q1 2026 Earnings Call, May 08, 2026
05-08	DiaSorin acquires over 330,000 treasury shares	AN

Share class: DiaSorin S.p.A.

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	55,948,257	21,123,208 ( 37.75 %)	2,632,381 ( 4.705 %)	37.75 %

Major shareholders: DiaSorin S.p.A.

Name	Equities	%	Valuation
IP Investimenti e Partecipazioni SRL 43.96 %	24,593,454	43.96 %	1 700 M €
Carlo Rosa 8.363 %	4,679,214	8.363 %	323 M €
Chen Menachem Even 4.2 %	2,350,000	4.2 %	162 M €
DIASORIN S.P.A. 3.34 %	1,868,672	3.34 %	129 M €
T. Rowe Price International Ltd. 3.032 %	1,696,073	3.032 %	117 M €
Helikon Investments Ltd. 2.489 %	1,392,552	2.489 %	96 M €
Denegri Family 1.019 %	570,000	1.019 %	39 M €
Goldman Sachs Asset Management International 0.9389 %	525,290	0.9389 %	36 M €
Fideuram Intesa Sanpaolo Private Banking SpA 0.5156 %	288,456	0.5156 %	20 M €
Mediolanum Gestione Fondi SGRpA 0.42 %	234,965	0.42 %	16 M €
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	52.91%
Individuals	13.58%
DiaSorin SpA	3.34%
Unknown	30.17%

Based on 1000 largest holdings

Geographical origin of shareholders

Italy	48.88%
Individuals	13.58%
United Kingdom	6.54%
Germany	0.41%
France	0.11%
Norway	0.09%
Luxembourg	0.09%
Switzerland	0.05%
New Zealand	0.03%
Portugal	0.02%
Sweden	0.01%
Spain	0.01%

Based on 1000 largest holdings

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2024, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Employees

3,242

Sector

Medical Equipment, Supplies & Distribution

Calendar

05-18 - Ex-dividend date - 1.3 EUR

More about the company